Marijke A M Von Der Mohlen

Title: Marijke A M Von Der Mohlen: Innovator in Therapeutic Protein Applications

Introduction

Marijke A M Von Der Mohlen is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of therapeutic protein applications, particularly in the treatment of conditions related to bacterial endotoxin exposure. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

His latest patents focus on the human therapeutic uses of bactericidal/permeability-increasing (BPI) protein products. These patents disclose methods for treating humans exposed to bacterial endotoxin in circulation. The administration of BPI protein products has been shown to result in serologically and hematologically verifiable alleviation of endotoxin-mediated increases in circulating cytokines, fibrinolysis, and coagulation factors. Additionally, changes in lymphocyte counts are observed upon such treatment. The patents also highlight the alleviation of endotoxin-mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).

Career Highlights

Marijke A M Von Der Mohlen is associated with Xoma Corporation, where he continues to advance his research and innovations. His work at Xoma Corporation has allowed him to explore the therapeutic applications of BPI protein products further.

Collaborations

He has collaborated with notable colleagues, including Nadav Friedmann and Patrick J Scannon, to enhance the research and development of therapeutic solutions.

Conclusion

Marijke A M Von Der Mohlen is a distinguished inventor whose work in therapeutic protein applications is paving the way for innovative treatments. His contributions to the field are significant and hold promise for future medical advancements.